In focus · trending topic

orphandisease

52 stories · following the connections

Abeona Therapeutics Receives FDA Orphan Drug Designation for EB-101 Gene Therapy Product for Patients with Epidermolysis Bullosa

By Nasdaq OMXMay 25, 2017, 12:10 PM UTC

Abeona Therapeutics to Present at Multiple Upcoming Conferences

By Nasdaq OMXMay 19, 2017, 12:06 PM UTC

Abeona Therapeutics to Present at Multiple Upcoming Conferences

By Nasdaq OMXMay 19, 2017, 12:06 PM UTC

Abeona Therapeutics Receives Regulatory Approval to Initiate Clinical Trial in Australia with ABO-102 Gene Therapy For Patients with MPS IIIA

By Nasdaq OMXMay 9, 2017, 12:05 PM UTC

Abeona Therapeutics Announces Gene Therapy Clinical Trial and Preclinical Program Presentations at ASGCT 20th Annual Meeting

By Nasdaq OMXMay 8, 2017, 12:05 PM UTC

Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences

By Nasdaq OMXApr 5, 2017, 11:43 AM UTC

Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights

By Nasdaq OMXMar 31, 2017, 12:05 PM UTC

Abeona Therapeutics to Present at Multiple Upcoming Investor Conferences

By Nasdaq OMXMar 13, 2017, 12:15 PM UTC